Skip to main content
OpenTrials
Completed

NCT Number: NCT03087331

An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain

This is a prospective, pre post, pilot cohort study to be conducted in patients with chronic pain, which is defined as pain that lasts beyond 3 months. To accomplish the primary and secondary objectives of the study, three phrases will be designed and completed during three months

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The PharmaShoppe

Kitchener, Ontario, N2G4X6, Canada

About this study

This study will evaluate the effectiveness of community-based pharmacist interventions on the quality of life of patients with chronic pain as determined by self-reported pain levels using an established scoring system. Participating pharmacists will enroll chronic pain patients from their normal practice to receive a consultation, which consists of an assessment of their current pain, a medication review, and education about their condition. Based on the information provided by the patient, the pharmacist will prepare a care plan, contact the patient's prescriber, and, in conjunction with the prescriber, implement the plan to help relieve their pain. Follow-up assessments will be done after 2 weeks, and 3 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 or older
  • Baseline average pain intensity using Brief Pain Inventory is 6 or higher
  • Ambulatory and able to attend the intervention
  • Complaining of pain for 3 months or longer

Exclusion criteria

  • Patients with malignant or cancer pain
  • Patients who are unable to communicate in English
  • Non-ambulatory and unable to attend the intervention at the participating site
  • Unable to give informed consent.

Treatment and study plan

medication reviews, assessment, recommendations, education.

Other

Primary outcomes

  1. Pain intensity change

    Time frame: baseline, 2 weeks follow-up, 3 months follow-up

    Pain intensity will be measured with Brief Pain Inventory pain intensity subscale, and will be measured 3 times in total

Secondary outcomes

  1. Pain interference

    Time frame: baseline, 2 weeks follow-up, 3 months follow-up

    Pain interference will be measured with Brief Pain Inventory pain interference subscale, and will be measured 3 times in total

  2. Quality of life change

    Time frame: baseline, 3 months follow-up

    quality of life will be measured using Short Form-36, and will be measured twice in total.

Other outcomes

  1. patient adherence

    Time frame: 2 weeks follow-up and 3 months follow-up

    Patient adherence will be measured using Morisky medication adherence scale-8, and will be measured at 2 weeks and 3 months follow-up.The Morisky medication adherence scale-8 will be used as supplementary data to further elucidate potential factors behind the observed outcomes.

Sponsors and collaborators

Lead sponsor

University of Waterloo

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 22, 2017
Registry last updated
Nov 17, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.